United States · FDA National Drug Code directory
lisinopril
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-417_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7
- Product NDC
- 76282-417
- Form
- TABLET
- Composition / generic term
- lisinopril
- Labeler
- Exelan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170322
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76282-417-01) · 76282-417-01
- 500 TABLET in 1 BOTTLE (76282-417-05) · 76282-417-05
- 1000 TABLET in 1 BOTTLE (76282-417-10) · 76282-417-10
- 180 TABLET in 1 BOTTLE (76282-417-18) · 76282-417-18
- 30 TABLET in 1 BOTTLE (76282-417-30) · 76282-417-30
- 45 TABLET in 1 BOTTLE (76282-417-45) · 76282-417-45
- 90 TABLET in 1 BOTTLE (76282-417-90) · 76282-417-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →